• Maxillofacial Plastic and Reconstructive Surgery
• /
• 제31권5호
• /
• pp.408-413
• /
• 2009

Odontogenic keratocyst (OKC) is a epithelial developmental cyst which were first described by Phillipsen in 1956. The frequency of OKC has been reported to vary from 3% to 11% of odontogenic cysts. The most characteristic clinical aspect of OKC is the high frequency of recurrence. The mechanism of recurrence is thought to be related to residues of cyst epithelium and an intrinsic growth potential following excision. And since the lining of the OKC is thin and friable, removal of the cyst in one piece may sometimes be difficult. Complete removal of the cyst lining without leaving behind remnants attached to the soft tissue or bone is necessary to avoid recurrence. Therapeutic approaches vary in different studies from marsupialization and enucleation, which may be combined with adjuvant therapy such as cryotherapy or Carnoy's solution, to marginal or radical resection. The recurrent rate varies from approximately 20% to 62%. And OKC in the angle-ramus region of the mandible had a higher tendency to recur, because of the difficulty in accessing and removing OKC from the ramus. By employing a sagittal splitting of the mandible a good surgical access was provided and cyst could be removed completely. We present an illustrative case of a small, lobulated OKC that involved ramus on mandible, and a review of the contemporary literature.

• 한국산림과학회지
• /
• 제98권1호
• /
• pp.26-32
• /
• 2009

현대 사회에는 도시 생활과 환경으로 인한 건강 문제가 증가하고 있는데 자연환경은 이러한 문제에 좋은 대안으로 대두되고 있다. 특히 숲과 나무는 예전부터 치유를 위한 공간으로 알려져 왔다. 주요우울장애는 매우 일반적이고 만성적인 질병으로 치료방법에는 약물치료와 다양한 심리치료가 포함되어 있다. 그러나 이러한 치료들은 환자들의 기능과 활동을 복귀시키는 것 보다는 기분 증상을 치료하는 것에 집중되어 있다. 본 연구에서는 우울증 환자들의 재활을 위한 산림활동 심리프로그램을 개발하였다. 본 연구에는 약물치료로 우울 증상은 개선되었으나 활동과 기능이 회복되지 못한 9명의 우울증 환자들이 참여하였다. 산림치유 프로그램은 4회기가 진행되었으며 매 회기마다 환자들의 우울증상과 심박변이도를 측정하였다. 4주간의 산림활동 심리프로그램 후 HRSD(Hamilton Rating Scale for Depression)로 측정된 우울감이 유의하게 감소하였으며, 건강관련 삶의 질을 측정하는 SF-36의 하위 척도의 점수가 상승하였고 심박통일성이 증가하였다. 본 예비적 연구 결과, 산림환경을 이용한 활동과 심리치료적 프로그램은 약물치료 중인 우울증 환자들의 기능회복과 재발방지에 긍정적인 역할을 할 가능성을 확인하였다.

• 한국융합학회논문지
• /
• 제11권9호
• /
• pp.51-57
• /
• 2020

본 연구는 칼텐본을 접목한 흉추가동운동이 폐기능에 미치는 영향을 알아보기 위하여 20대 대학생 20명을 대상으로 4주간 실시하였다. 실험대상자 20명을 대상으로 실험군, 대조군으로 무작위 동공선택방식으로 그룹 배정을 하였다. 실험군은 횡격막 호흡운동 15분과 칼텐본을 적용한 흉추가동운동 15분으로 구성되고, 대조군은 횡격막 호흡운동으로 30분간 훈련하였으며, 두 군의 운동프로그램은 주 3회 4주간 실시하였다. 측정은 폐기능을 측정하여 자료를 분석하였다. 실험 전·후 폐기능을 분석해 보면, 실험군은 TV, IRV에서 유의하게 증가하였으며, 실험후에 두 집단간의 변화검증에서도 TV와 IRV에서 유의한 차이가 나타났다. 본 연구를 통해 칼텐본을 이용한 흉추가동운동이 폐 기능에 더 긍정적인 효과를 주는 것을 알 수 있었다. 앞으로 임상에서 호흡훈련 시 일반적인 호흡훈련에 흉추가동운동을 함께 접목하는 치료방법이 적극적으로 중재되기를 기대하며 다양한 추가운동프로그램의 개발이 필요할 것으로 사료된다.

• Radiation Oncology Journal
• /
• 제34권1호
• /
• pp.34-44
• /
• 2016

Purpose: A prospective phase II trial was conducted to evaluate the effectiveness and toxicity of regional hyperthermia and whole liver irradiation (WLI) for numerous chemorefractory liver metastases from colorectal cancer. Materials and Methods: Enrolled patients had numerous chemorefractory hepatic metastases from colorectal cancer. Five sessions of hyperthermia and seven fractions of 3-gray WLI were planned. Health-related quality of life (HRQoL) was determined using the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire C-30 and the Functional Assessment of Cancer Therapy-Hepatobiliary version 4.0. Objective and pain response was evaluated. Results: A total of 12 patients consented to the study and the 10 who received WLI and hyperthermia were analyzed. WLI was completed as planned in nine patients and hyperthermia in eight. Pain response was partial in four patients and stable in four. Partial objective response was achieved in three patients (30.0%) and stable disease was seen in four patients at the 1-month follow-up. One patient died 1 month after treatment because of respiratory failure related to pleural metastasis progression. Other grade III or higher toxicities were detected in three patients; however, all severe toxicities were related to disease progression rather than treatment. No significant difference in HRQoL was noted at the time of assessment for patients who were available for questionnaires. Conclusion: Combined WLI and hyperthermia were well tolerated without severe treatment-related toxicity with a promising response from numerous chemorefractory hepatic metastases from colorectal cancer.

• 한국임상수의학회지
• /
• 제24권3호
• /
• pp.432-436
• /
• 2007

개 모낭충증의 새로운 치료법을 확립하기 위하여 항생제의 약침과 일반 치료의 병행을 이용한 치료 효과를 조사하였다. 본 연구에서는 모낭충으로 진단된 개 3두를 이용하였다. Enrofloxacin의 약침을 폐수(BL13) 위중(BL40), 대추(GV14), 족삼리(ST36), 합곡(LI04), 곡지(LI11) 및 삼음교(SP06)의 혈위에 각각 5주간 실시하였다. 또한 일반 치료법인 invermectin과 0.05% amitraz 약욕을 5주간 추가로 실시하였다. 소양증, 찰과상, 홍반 및 탈모와 같은 임상증상은 약침과 일반치료에 의해서 치료 전에 비하여 현저하게 완화되었다. Case 1은 4주 후에 완치되었고, case 2는 5주 후에 증상이 약간 잔존하였으며, 그리고 case 3은 5주 후에 완치되었다. 혈중 백혈구 수는 치료와 더불어 모든 케이스에서 감소하는 경향을 보였으나, 호중구/림프구 비율은 일정한 경향을 나타내지 않았다. 5주째 병리조직 검사 소견상에서 case 1과 case 3은 뚜렷한 병리조직학적 변화가 관찰되지 않았으나, case 2는 경도의 변화가 관찰되었다. 결론적으로 개 모낭충에 이환된 본 환축들은 항생제 약침과 일반 치료법의 병행으로 양호한 치료반응을 나타낸 증례이었다.

• 대한한방소아과학회지
• /
• 제31권1호
• /
• pp.25-42
• /
• 2017

Objectives The goal of this review was to investigate clinical, experimental and literature studies of Korean medicine on atopic dermatitis (AD) of Korean children in Korean medicine literature, seeking for the better research methods for more effective treatments. Methods Electronic investigations were practiced on AKOP (The Association of Korean Oriental Pediatrics, http://www.akop.or.kr) to collect theses which were published by J Pediatr Korean Med. The key word 'Atopy' was used for searching to ensure that every related thesis was collected. The publication date was limited from 1996 to 2016. The selected literatures were assessed mainly according to distributions of study type, publication year, scale, treatment and its efficacy. Results 55 papers were selected from 59 studies. In these collected 55 related theses, there were 29 experimental studies (52.73%), 18 clinical studies (32.73%), 8 review studies (14.55%). In the 29 experimental studies, there were 20 studies (68.97%) using NC/Nga mouse as subjects. The mite antigen was used to trigger AD by 8 studies (27.59%). The studies have been utilizing DNCB and DNFB instead of mite antigen since 2011. All the experimental studies showed that the Korean medicine was effective in AD. In total 18 clinical studies, 3 studies (16.67%) were case reports, only 1 thesis (5.56%) was conducted by case control study and the rest were case series studies. 7 studies (38.89%) of 18 studies diagnosed AD according to Hanifin and Rajka's diagnostic criteria (1980), only 1 study (5.56%) according to the Korean standard and the rest 10 studies (55.56%) didn't mention diagnostic criteria. 12 clinical studies (66.67%) showed efficacy in treating AD. There were 10 studies (55.56%) only employing internal treatments and 1 thesis (5.56%) didn't mention the exact prescription. Naesowhajungtang-kamibang, Saenghyeoryunbue-um were used 3 times (16.67%) as the internal medicine respectively. 5 theses (27.78%) were combined with acupuncture therapy. Hegu (LI4), Sanyinjiao (SP6) were used in 4 theses, and Taichong (LR3), Quchi (LI11), Zusanli (ST36) in 3 theses. The number of acupoints chosen from The Spleen meridian of Foot-Taiyin was the largest. There were 8 review theses. 2 were about the foreign oriental medicine, 3 were about the external medicine or external treatment methods, and 3 other studies were about severity scoring systems, the methodological study in the latest clinical study, overview for pattern and results of herbal medicine-derived AD clinical researches. Conclusions The experimental studies and clinical studies showed the effectiveness of Korean medicine treatments. However, this study still needs improving by conducting more comparative studies and using better research methods, in order to find more effective treatments to improve clinical efficacy.

• 대한한방내과학회지
• /
• 제42권5호
• /
• pp.833-845
• /
• 2021

Parkinson's syndrome is a degenerative brain disease that presents characteristic motor symptoms of tremor, rigidity, and gait disturbance. In addition to these motor symptoms, Parkinson's syndrome also presents non-motor symptoms (NMSs) such as sleep disturbance and cognitive decline. NMSs reduce patient's quality of life and psychosocial functioning and cause economic burden on the patient, so appropriate evaluation and treatment are required. Lewy body dementia is one of the several diseases belonging to Parkinson's syndrome. Its symptoms such as cognitive function, memory impairment, and hallucinations occur with Parkinsonism. Although drug therapy is being used with drug treatment to treat non-motor symptoms, it has limitations such as side effects, which stimulated interest in other complementary treatment methods such as oriental medicine treatment, dance, and yoga. The patient in this case complained of tremor in the right upper extremity, muscle hypertension and pain, and persistent vision, memory, and cognitive decline. The patient was diagnosed with probable Lewy body dementia. The patient was hospitalized for 4 months and received acupuncture and herbal medicines. After treatment, the patient's NMS scale scores decreased from 90 to 63, and the Unified Parkinson's Disease Rating Scale scores (summed I, II, and III) decreased from 17 points to 8 points. The Beck Depression Inventory score decreased from 22 points to 13 points. In addition, the patient's subjective evaluation revealed improvement. In this case, a patient diagnosed with probable Lewy body dementia who did not respond to the standard treatment and did not want to take medications showed improvement in not only motor symptoms but also NMSs after integrative Korean medicine treatment.

• 한국임상약학회지
• /
• 제29권3호
• /
• pp.166-172
• /
• 2019

Background: Hypercalcemia is an important metabolic emergency condition in cancer patients. Bisphosphonate is the treatment of choice for hypercalcemia, whereas calcitonin and hydration with furosemide are recommended for acute supportive therapy. However, data regarding real-world treatment patterns and outcomes of pharmacological treatments are limited. Therefore, we aimed to investigate the treatment patterns and clinical outcomes of hypercalcemia treatment in solid tumor patients. Methods: Electronic medical records of 123 adults with solid cancers and albumin-corrected calcium levels >10.5 mg/dL or ionized calcium levels >1.35 mmol/L were reviewed. We retrospectively analyzed the pharmacological treatment and recovery rate according to the severity of hypercalcemia. Results: A total of 177 cases were identified, of which 49 were not treated and 30 were treated with hydration only. In moderate-to-severe cases, 86.5% received pharmacological treatment. Thirty-four cases (19.2%) were treated with bisphosphonate alone and 58 cases (32.8%) were treated with bisphosphonate and calcitonin. In mild hypercalcemia cases, the recovery rate was higher for those receiving hydration only or pharmacological treatment (79.7%) than for those receiving no treatment (61.4%, p = 0.041). Most moderate-to-severe cases were treated with medication and of those treated, 56.3% recovered. The recovery rate was lower in those treated with bisphosphonate alone (38.2%) than in those who underwent calcitonin combination treatment (73.7%, p = 0.001). Conclusions: Bisphosphonate combined with calcitonin was found to be more effective than bisphosphonate alone for the treatment of moderate-to-severe hypercalcemia. Considering the current shortage of calcitonin, further efforts are required to ensure its stable supply.

• Molecules and Cells
• /
• 제42권6호
• /
• pp.448-459
• /
• 2019

The phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway is a promising target for gastric cancer (GC) treatment; however the efficacy of PI3K/mTOR dual inhibitors in GC has not yet been maximized. Additionally, the effect of autophagy regulation by PI3K/mTOR dual inhibitors has not been clearly elucidated in GC treatment. We aimed to show that our newly developed PI3K/mTOR dual inhibitor, CMG002, when combined with an autophagy inhibitor, chloroquine (CQ), potently induces effective cancer cell death in Epstein-Barr virus (EBV)-associated gastric cancer (EBVaGC) cells, where both the PI3K/AKT/mTOR and autophagy pathways play important roles in disease pathogenesis. EBV- and mock-infected AGS and NUGC3 GC cell lines were treated with CMG002 +/- CQ. PI3K/AKT/mTOR signaling pathway mediators, cellular apoptosis and autophagy markers were confirmed by Western blot assay. Cell viability was assessed using the Cell Counting Kit-8 (CCK-8) assay. CMG002 effectively blocked the PI3K/AKT/mTOR pathway by markedly decreasing phosphorylation of AKT and its downstream mediator S6. CMG002 induced G0/G1 cell cycle arrest and enhanced apoptotic cell death in AGS and NUGC3 cells, particularly EBV-infected cells compared with mock-infected cells, as confirmed by flow cytometric analyses and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assays. The combination of CMG002 plus CQ synergistically increased apoptotic cell death in EBV-infected GC cell lines when compared with CMG002 alone (P < 0.05). Our results suggest that the new PI3K/mTOR dual inhibitor, CMG002, when used in combination with the autophagy inhibitor, CQ, provides enhanced therapeutic efficacy against EBVaGC.

• 대한한방내과학회지
• /
• 제41권6호
• /
• pp.1231-1244
• /
• 2020

Objective: This study was conducted to report the glucose-lowering effect and safety of herbal extracts in patients with type 2 diabetes mellitus. Methods: We investigated 21 patients with type 2 diabetes mellitus who were administered Daeshiho-tang, Bojungikgi-tang, Jowiseunggi-tang, and Hoechunyanggyeok-san at Kyung-Hee University Korean Medical Hospital from 2014 to 2019. The hypoglycemic effect of the herbal extracts was assessed by comparing blood glucose levels, including fasting blood sugar (FBS) and 2-hour postprandial glucose (PP2) levels. For safety assessment, the effects of herbal extracts on liver and kidney function were analyzed by liver function tests, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ-glutamyltransferase (GGT), and kidney function tests, including blood urea nitrogen (BUN) and creatinine (Cr). Patients were stratified according to their glycated hemoglobin (<6.5 or >6.5) levels and the kind of herbal extract used for treatment. Results: After administration of herbal extracts, FBS and PP2 significantly decreased to 20.24 mg/dL and 35.0 mg/dL respectively. Subgroup analysis revealed that, regardless of the glycated hemoglobin level, FBS and PP2 were significantly reduced in both groups. The safety profile showed no significant difference before and after taking herbal extracts. Conclusions: Daeshigo-tang, Bojungikgi-tang, Jowiseunggi-tang, and Hoechunyanggyeok-san may show the further glucose-lowering effects on patients with type 2 diabetes mellitus who have already treated with anti-hyperglycemic agents.